The Patent Finder

Anavex Life Sciences Corp.

Also on record
Records under this name other than the patents Anavex Life Sciences Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.

Back to Anavex Life Sciences Corp.

PatentTitleStatus Expires Confidence
13/201,271Sigma Receptors Ligands with Anti-Apoptotic And/Or Pro-Apoptotic Properties, Over Cellular Mechanisms, Exhibiting Prototypical Cytoprotective and Also Anticancer Activity
Abandoned
Abandoned Jul 29, 2014
AbandonedAbandoned Jul 29, 2014
15/695,170ANAVEX2-73 and Certain Anticholinesterase Inhibitors Composition and Method for Neuroprotection
Abandoned
Abandoned Aug 19, 2019
AbandonedAbandoned Aug 19, 2019
18/552,305Prevention and Treatment of Coronavirus Infection
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/712,387Therapy Selection and Treatment of Neurodegenerative Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/941,714Treatment of Cardiac Dysfunction
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/984,748A2-73 Crystalline Polymorph Compositions of Matter and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/002,135Enantiomers of A2-73, Analogues, and Sigma Agonist Activity
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/094,476SIGMA-1 Receptor Agonist Systolic Blood Pressure Therapy
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/099,386Compositions and Methods for Prevention of Cognitive Decline Caused by Degenerative Diseases
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/099,422Therapy Selection and Treatment of Neurodegenerative Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 17 records shown.
Pro members see all 17.
Pro members: see all 17 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited